Author

Cheyanne K. Shinn

University of California San DiegoORCID 0000-0001-5807-756XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Catherina L. SalangaiD· 1 shared Jorge Silvio GutkindiD· 1 shared Robert Saddawi‐KonefkaiD· 1 shared Shiruyeh SchokrpuriD· 1 shared Tracy M. HandeliD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Catherina L. SalangaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 24, 2025

Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma

Cheyanne K. Shinn, Robert Saddawi‐Konefka, Catherina L. Salanga…·Tracy M. Handel

This study shows that delivering CXCL10 into tumors enhances immune cell infiltration, activation, and anti-tumor responses, and improves the effectiveness of immunotherapy in head and neck squamous cell carcinoma.

10 citations

mouseexperimental assay

𝕏 PostBluesky